Morven Wilkie

768 total citations
12 papers, 274 citations indexed

About

Morven Wilkie is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Morven Wilkie has authored 12 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Morven Wilkie's work include Tuberculosis Research and Epidemiology (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Immune responses and vaccinations (5 papers). Morven Wilkie is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Immune responses and vaccinations (5 papers). Morven Wilkie collaborates with scholars based in United Kingdom, Netherlands and Italy. Morven Wilkie's co-authors include Helen McShane, Stephanie A. Harris, Iman Satti, Lisa Stockdale, Alice Minhinnick, Samantha Vermaak, Paul Moss, Zita‐Rose Manjaly Thomas, Alison M. Lawrie and Stuart Schembri and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Morven Wilkie

12 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morven Wilkie United Kingdom 9 198 162 89 47 24 12 274
Dearbhla M Murphy Ireland 6 102 0.5× 161 1.0× 100 1.1× 53 1.1× 17 0.7× 14 285
Paige M Mortimer United Kingdom 6 185 0.9× 63 0.4× 59 0.7× 62 1.3× 19 0.8× 7 335
April K. Randhawa United States 10 174 0.9× 167 1.0× 121 1.4× 44 0.9× 28 1.2× 13 336
Julie Frouard United States 8 210 1.1× 111 0.7× 57 0.6× 59 1.3× 8 0.3× 12 343
István Jankovics Hungary 10 112 0.6× 91 0.6× 299 3.4× 41 0.9× 15 0.6× 22 362
Daniil Korenkov Russia 13 139 0.7× 180 1.1× 330 3.7× 79 1.7× 24 1.0× 27 446
Karol Szymański Poland 7 104 0.5× 63 0.4× 190 2.1× 36 0.8× 45 1.9× 44 292
Momodou Cox Gambia 9 107 0.5× 227 1.4× 131 1.5× 36 0.8× 39 1.6× 13 356
Kinola J.N. Williams Canada 7 245 1.2× 55 0.3× 120 1.3× 31 0.7× 19 0.8× 9 336
S. Lau China 5 280 1.4× 32 0.2× 77 0.9× 42 0.9× 20 0.8× 5 345

Countries citing papers authored by Morven Wilkie

Since Specialization
Citations

This map shows the geographic impact of Morven Wilkie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morven Wilkie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morven Wilkie more than expected).

Fields of papers citing papers by Morven Wilkie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morven Wilkie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morven Wilkie. The network helps show where Morven Wilkie may publish in the future.

Co-authorship network of co-authors of Morven Wilkie

This figure shows the co-authorship network connecting the top 25 collaborators of Morven Wilkie. A scholar is included among the top collaborators of Morven Wilkie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morven Wilkie. Morven Wilkie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Álvarez, Marco Polo Peralta, Morven Wilkie, Daniel Wright, et al.. (2022). Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination. Frontiers in Immunology. 12. 798207–798207. 16 indexed citations
2.
Wilkie, Morven, Rachel Tanner, Daniel Wright, et al.. (2022). Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study. Scientific Reports. 12(1). 7808–7808. 5 indexed citations
3.
Riste, Michael, Julia L. Marshall, Iman Satti, et al.. (2021). Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults. Vaccines. 9(4). 396–396. 9 indexed citations
4.
Wilkie, Morven, et al.. (2019). Fungal diseases at the medical front door. British Journal of Hospital Medicine. 80(3). 157–161. 2 indexed citations
5.
Wilkie, Morven, Iman Satti, Alice Minhinnick, et al.. (2019). A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults. Vaccine. 38(4). 779–789. 63 indexed citations
6.
Tanner, Rachel, Steven G. Smith, Krista E. van Meijgaarden, et al.. (2019). Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells. Journal of Immunological Methods. 469. 1–10. 19 indexed citations
7.
Thomas, Zita‐Rose Manjaly, Iman Satti, Julia L. Marshall, et al.. (2019). Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial. PLoS Medicine. 16(4). e1002790–e1002790. 49 indexed citations
8.
Minhinnick, Alice, Iman Satti, Stephanie A. Harris, et al.. (2016). A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults. Vaccine. 34(11). 1412–1421. 31 indexed citations
9.
Wilkie, Morven, Simon Finch, & Stuart Schembri. (2015). Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease—The Shifting Treatment Paradigm. COPD Journal of Chronic Obstructive Pulmonary Disease. 12(5). 582–590. 20 indexed citations
10.
Minhinnick, Alice, Stephanie A. Harris, Morven Wilkie, et al.. (2015). Optimization of a Human Bacille Calmette-Guérin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity. The Journal of Infectious Diseases. 213(5). 824–830. 26 indexed citations
11.
Sheehan, Sharon R., Stephanie A. Harris, Iman Satti, et al.. (2015). A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults. PLoS ONE. 10(11). e0141687–e0141687. 28 indexed citations
12.
Wilkie, Morven, et al.. (2012). Elevated creatinine is a sensitive severity marker in community acquired pneumonia. 40. 2506. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dearbhla M Murphy Breakdown of academic impact, for papers by Paige M Mortimer Breakdown of academic impact, for papers by April K. Randhawa Breakdown of academic impact, for papers by Julie Frouard Breakdown of academic impact, for papers by István Jankovics Breakdown of academic impact, for papers by Daniil Korenkov Breakdown of academic impact, for papers by Karol Szymański Breakdown of academic impact, for papers by Momodou Cox Breakdown of academic impact, for papers by Kinola J.N. Williams Breakdown of academic impact, for papers by S. Lau
Rankless by CCL
2026